12:00 AM
Nov 01, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Adcon-L bioresorbable barrier gel regulatory update

The FDA informed GLIA that issues raised in a warning letter last month concerning GLIA's contract manufacturing firm, European Medical Contract Manufacturing B.V. (Nijmegen, the...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >